Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

More articles from 5.1 Airway Pharmacology and Treatment

  • Budesonide and fluticasone propionate exertdifferential effects on human bronchial epithelial cells exposed to streptococcus pneumoniae and viral mimetic
    H. Irene Heijink, Marnix Jonker, Dirkje S. Postma, Maarten van den Berge
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA5061; DOI: 10.1183/13993003.congress-2016.PA5061
  • Pharmacological characterization of the mechanism of action leading to synergism between glycopyrronium bromide and indacaterol fumarate
    Luigino Calzetta, Paola Rogliani, Ermanno Puxeddu, Josuel Ora, Francesco Facciolo, Maria Gabriella Matera, Mario Cazzola
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA5057; DOI: 10.1183/13993003.congress-2016.PA5057
  • Neutrophils in bronchial mucosa, sputum and blood after administration of the CXCR2-antagonist AZD5069 - An explorative study in neutrophilic asthma
    Henrik Watz, Anne Kirsten, Frauke Pedersen, Torsten Goldmann, Florian Stellmacher, Mohib Uddin, Bengt Larsson, Gerhard Böttcher, Anna Malmgren, Marteen Kraan, Klaus Rabe
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4892; DOI: 10.1183/13993003.congress-2016.PA4892
  • Tiotropium reduces oral prednisone requirements while improving respiratory function in patients with severe persistent asthma
    Bashir Omarjee
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4904; DOI: 10.1183/13993003.congress-2016.PA4904
  • Safety, tolerability and pharmacokinetics of CHF 6001, a novel selective inhaled PDE4 inhibitor, in healthy volunteers
    Germano Lucci, Fabrizia Mariotti, Debora Santoro, Daniela Acerbi, Gianluigi Poli, Marie-Anna Nandeuil
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4086; DOI: 10.1183/13993003.congress-2016.PA4086
  • Efficacy of omalizumab in Polish real-world patients
    Agnieszka Gawlewicz-Mroczka, Weronika Zastrzezynska, Marek Przybyszowski, Adam Cmiel, Krzysztof Sladek
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4120; DOI: 10.1183/13993003.congress-2016.PA4120
  • Long-term inhaled corticosteroid use in COPD and the risk of fracture in men and women
    Samy Suissa, Janie Coulombe, Pierre Ernst
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4048; DOI: 10.1183/13993003.congress-2016.PA4048
  • Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients
    Elena Cabezas Pastor, Andrés Giménez Velando, Herminia Ortiz Mayoral, Reyes Calzado López, María Teresa Pérez Warnisher, Diana Sánchez Mellado, Germán Peces-Barba Romero, Felipe Villar Álvarez
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4054; DOI: 10.1183/13993003.congress-2016.PA4054
  • Characterization of readmissions in patients hospitalized with COPD exacerbation
    Andres Gimenez Velando, Elena Cabezas Pastor, Reyes Calzado López, Herminia Ortiz Mayoral, Alba Naya Prieto, Pilar Carballosa De Miguel, Germán Peces-Barba Romero, Felipe Villar Álvarez
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4073; DOI: 10.1183/13993003.congress-2016.PA4073
  • Roflumilast N-oxide combined with PI3Kδ inhibitor improves the phenotype of early-onset COPD
    Sonia Contreras, Javier Milara, Adela Serrano, Esteban Morcillo, Julio Cortijo
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4087; DOI: 10.1183/13993003.congress-2016.PA4087

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 106

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society